Farwell Wildon has filed 20 insider transactions across 1 company since March 2023.
Most recent transaction: a sale of 2060 shares of Dyne Therapeutics, Inc. ($DYN) on August 19, 2024.
Activity breakdown: 0 open-market purchases and 18 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 19, 2024 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 2060 | $45.01 | 143,483.0000 | 0 | 1.42% | 0.00% |
| Aug. 19, 2024 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 261 | $46.00 | 143,222.0000 | 0 | 0.18% | 0.00% |
| June 11, 2024 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1628 | $31.27 | 146,551.0000 | 0 | 1.10% | 0.00% |
| June 11, 2024 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1008 | $31.27 | 145,543.0000 | 0 | 0.69% | 0.00% |
| May 16, 2024 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1956 | $28.20 | 148,604.0000 | 0 | 1.30% | 0.00% |
| May 16, 2024 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 425 | $28.59 | 148,179.0000 | 0 | 0.29% | 0.00% |
| March 11, 2024 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1585 | $25.70 | 151,590.0000 | 0 | 1.03% | 0.00% |
| March 12, 2024 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1030 | $25.58 | 150,560.0000 | 0 | 0.68% | 0.00% |
| March 7, 2024 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 8364 | $25.80 | 154,732.0000 | 0 | 5.13% | 0.00% |
| March 7, 2024 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1557 | $26.20 | 153,175.0000 | 0 | 1.01% | 0.00% |
| Feb. 28, 2024 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 407 | $25.00 | 163,096.0000 | 0 | 0.25% | 0.00% |
| Feb. 12, 2024 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 5493 | $25.07 | 163,503.0000 | 0 | 3.25% | 0.00% |
| Jan. 26, 2024 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 100 | $25.00 | 168,996.0000 | 0 | 0.06% | 0.00% |
| Dec. 11, 2023 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1688 | $10.72 | 170,074.0000 | 0 | 0.98% | 0.00% |
| Dec. 12, 2023 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 978 | $10.55 | 169,096.0000 | 0 | 0.58% | 0.00% |
| Nov. 15, 2023 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | A | Common Stock | 82512 | $0.00 | 171,762.0000 | 0 | 92.45% | 0.00% |
| Nov. 15, 2023 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | A | Stock Option (right to buy) | 32131 | $0.00 | 32,131.0000 | 0 | 9999.99% | 0.00% |
| Sept. 12, 2023 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1707 | $10.41 | 89,250.0000 | 0 | 1.88% | 0.00% |
| June 13, 2023 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 1698 | $12.43 | 90,957.0000 | 0 | 1.83% | 0.00% |
| March 14, 2023 | Dyne Therapeutics, Inc. | $DYN | Farwell Wildon | Chief Medical Officer | S | Common Stock | 7441 | $13.33 | 92,655.0000 | 0 | 7.43% | 0.00% |